Dow Down 0.18% Nasdaq Up 0.39%

XOMA Corporation (XOMA)

-NasdaqGM
4.31 Down 0.07(1.60%) Sep 2, 4:00PM EDT
|After Hours : 4.25 Down 0.06 (1.39%) Sep 2, 7:57PM EDT
Prev Close:4.38
Open:4.40
Bid:N/A
Ask:7.33 x 1000
1y Target Est:9.00
Beta:2.66
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.25 - 4.41
52wk Range:3.42 - 9.57
Volume:905,214
Avg Vol (3m):1,346,300
Market Cap:461.50M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for XOMA

Comparison

Symbol% ChgMkt Cap
XOMADown 1.60%461.50M
NVSUp 4.31%227.36B
REGNUp 2.58%36.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback